Back
Biomarin Pharmaceutical Vs. Merck & Industry Stock Comparison
Buy
61
BMRN
Biomarin Pharmaceutical
Last Price:
64.25
Seasonality Move:
12.47%
Sell
25
MRK
Merck &
Last Price:
99.13
Seasonality Move:
3.55%
Buy
61
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $64.26. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Merck & (MRK)
is a Sell
Is Merck & a Buy, Sell or Hold?
- The current Merck & [MRK] share price is $99.18. The Score for MRK is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- MRK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $64.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.96 | Sell |
Relative Strength Index (14 RSI): | 38.59 | Sell |
Chaikin Money Flow: | 518116 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.94 - 69.24) | Sell |
Bollinger Bands (100): | (67.93 - 87.19) | Sell |
MRK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.64 | Sell |
Relative Strength Index (14 RSI): | 39.25 | Sell |
Chaikin Money Flow: | -11216635 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (98.27 - 104.65) | Sell |
Bollinger Bands (100): | (104.64 - 121.72) | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 63.73 | Buy |
20-day SMA: | 65.69 | Sell |
50-day SMA: | 68.56 | Sell |
200-day SMA: | 81.05 | Sell |
8-day EMA: | 63.9 | Buy |
20-day EMA: | 65.57 | Sell |
50-day EMA: | 69.74 | Sell |
200-day EMA: | 79.39 | Sell |
MRK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 97.84 | Buy |
20-day SMA: | 100.37 | Sell |
50-day SMA: | 107.22 | Sell |
200-day SMA: | 120.42 | Sell |
8-day EMA: | 98.61 | Buy |
20-day EMA: | 100.63 | Sell |
50-day EMA: | 105.79 | Sell |
200-day EMA: | 114.66 | Sell |
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.
Merck & Earnings Growth & MRK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.36 per share, and an increase next year of $1.75 per share.
Biomarin Pharmaceutical Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Merck & Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |